Abstract
In recent years new oral anticoagulants have been evaluated in the prevention of venous thromboembolism (VTE) after elective hip or knee arthroplasty, atrial fibrillation to prevent ischemic stroke and in the treatment of acute VTE. While two oral anticoagulants, dabigatran and rivaroxaban, have become available for the prevention of VTE in orthopaedic surgery, other indications still are under evaluation or await approval. There are also areas where these novel drugs have not yet been evaluated. These include patients with acute VTE and cancer, pregnant patients with acute VTE and patient with either rheumatic heart valve disease or artificial heart valves. Finally, in acute care settings, where anticoagulant reversibility is critical, such as during and after coronary artery bypass surgery or acute PCI setting in patients with high bleeding risk, novel intravenous anticoagulant drugs with either short half life or specific antidotes may have added value. This article will focus on these unresolved issues.
Keywords: Thrombosis, new anticoagulants, pregnancy, heart valves, cancer, Anticoagulants, venous thromboembolism, knee arthroplasty, atrial fibrillation, ischemic stroke, dabigatran, rivaroxaban, orthopaedic surgery, rheumatic heart valve disease, artificial heart valves, acute PCI setting, intravenous anticoagulant drugs, coronary artery bypass, tumour, Low-molecular-weight heparin, fondaparinux, hromboprophylaxis, renal dysfunction, creatinine clearance, apixaban, hepatotoxic, hepatic metastases, chemotherapy, Vitamin K antagonists, anti-factor Xa, heparin induced thrombocytopenia, Otamixaban, Eptifibatide in Non-ST, Elevation Acute Coronary Syndrome, myocardial infarction, RB006, antithrombotic prophylaxis, hypercoagulable state
Current Pharmaceutical Design
Title: Further Issues with New Oral Anticoagulants
Volume: 16 Issue: 31
Author(s): M. V. Huisman
Affiliation:
Keywords: Thrombosis, new anticoagulants, pregnancy, heart valves, cancer, Anticoagulants, venous thromboembolism, knee arthroplasty, atrial fibrillation, ischemic stroke, dabigatran, rivaroxaban, orthopaedic surgery, rheumatic heart valve disease, artificial heart valves, acute PCI setting, intravenous anticoagulant drugs, coronary artery bypass, tumour, Low-molecular-weight heparin, fondaparinux, hromboprophylaxis, renal dysfunction, creatinine clearance, apixaban, hepatotoxic, hepatic metastases, chemotherapy, Vitamin K antagonists, anti-factor Xa, heparin induced thrombocytopenia, Otamixaban, Eptifibatide in Non-ST, Elevation Acute Coronary Syndrome, myocardial infarction, RB006, antithrombotic prophylaxis, hypercoagulable state
Abstract: In recent years new oral anticoagulants have been evaluated in the prevention of venous thromboembolism (VTE) after elective hip or knee arthroplasty, atrial fibrillation to prevent ischemic stroke and in the treatment of acute VTE. While two oral anticoagulants, dabigatran and rivaroxaban, have become available for the prevention of VTE in orthopaedic surgery, other indications still are under evaluation or await approval. There are also areas where these novel drugs have not yet been evaluated. These include patients with acute VTE and cancer, pregnant patients with acute VTE and patient with either rheumatic heart valve disease or artificial heart valves. Finally, in acute care settings, where anticoagulant reversibility is critical, such as during and after coronary artery bypass surgery or acute PCI setting in patients with high bleeding risk, novel intravenous anticoagulant drugs with either short half life or specific antidotes may have added value. This article will focus on these unresolved issues.
Export Options
About this article
Cite this article as:
V. Huisman M., Further Issues with New Oral Anticoagulants, Current Pharmaceutical Design 2010; 16 (31) . https://dx.doi.org/10.2174/138161210793563356
DOI https://dx.doi.org/10.2174/138161210793563356 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Potential of Nucleic Acid-Based Drugs in Coronary Hyper- Proliferative Vascular Diseases
Current Medicinal Chemistry Corticosteroids for the Inflammatory Response to Cardiopulmonary Bypass: An Update
Current Pharmaceutical Design Microfluidic Devices for Circulating Tumor Cells Isolation and Subsequent Analysis
Current Pharmaceutical Biotechnology Use of Chronic Disease Registries to Optimize Cardiovascular Health
Current Vascular Pharmacology Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19
Current Cardiology Reviews D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function
Current Topics in Medicinal Chemistry Pharmacogenomics of Oral Antithrombotic Drugs
Current Pharmaceutical Design The Multiple Electrocardiographic Manifestations of Ventricular Repolarization Memory
Current Cardiology Reviews Local Delivery of Therapeutics for Percutaneous Coronary Intervention
Current Drug Delivery Coronary CT and the Coronary Calcium Score, the Future of ED Risk Stratification?
Current Cardiology Reviews Inhibitors of the Calcineurin / NFAT Pathway
Current Medicinal Chemistry Mechanisms of Fetal and Neonatal Renal Impairment by Pharmacologic Inhibition of Angiotensin
Current Medicinal Chemistry Oxidative Stress and the Pathogenesis of Atrial Fibrillation
Current Cardiology Reviews Current Concepts on Prenatal Diagnosis and Management of Fetal Tachyarrythmias
Current Cardiology Reviews Hydrogels in Tissue Engineering: Scope and Applications
Current Pharmaceutical Biotechnology The Role of Mesenchymal Stem Cells in Immune Response
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Drug Treatment of Obesity: Established and Emerging Therapies
Mini-Reviews in Medicinal Chemistry Structural Chromosome Abnormalities Associated with Obesity: Report of Four New Subjects and Review of Literature
Current Genomics Transcranial Doppler Ultrasonography: Current Status
Current Medical Imaging The Potential Application of Biomaterials in Cardiac Stem Cell Therapy
Current Medicinal Chemistry